Cargando…
Projected number of osteoarthritis patients in Austria for the next decades – quantifying the necessity of treatment and prevention strategies in Europe
BACKGROUND: The present study aimed to predict the expected number of patients with osteoarthritis (OA) in Austria up to the year 2080. METHODS: Demographic data and population projections between 2019 and 2080 were obtained from European authorities. Information about recent age- and sex-stratified...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830022/ https://www.ncbi.nlm.nih.gov/pubmed/35139829 http://dx.doi.org/10.1186/s12891-022-05091-5 |
_version_ | 1784648191043436544 |
---|---|
author | Hitzl, Wolfgang Stamm, Tanja Kloppenburg, Margreet Ritter, Markus Gaisberger, Martin van der Zee-Neuen, Antje |
author_facet | Hitzl, Wolfgang Stamm, Tanja Kloppenburg, Margreet Ritter, Markus Gaisberger, Martin van der Zee-Neuen, Antje |
author_sort | Hitzl, Wolfgang |
collection | PubMed |
description | BACKGROUND: The present study aimed to predict the expected number of patients with osteoarthritis (OA) in Austria up to the year 2080. METHODS: Demographic data and population projections between 2019 and 2080 were obtained from European authorities. Information about recent age- and sex-stratified prevalence of patients with self-reported physician-diagnosed OA was obtained from the Austrian Health Interview Survey (n = 15,771). Projections were stratified by age and sex; sensitivity analyses were performed based on aging, main (most likely), and growth scenarios of the population. RESULTS: Based on the projection, the overall increase in the total number of patients with OA from 2019 to 2080 will be 38% for men and women. In 2019, the highest number of OA-patients nested in the groups of persons aged 70-79 (n = 238,749) and 60-69 (n = 237,729) years. In 2080, the 80+ age group is predicted to have the highest number of OA with 421,548 individuals (i.e. factor 3.45 and factor 2.48 increase in the male and female group, respectively, compared to 2019), followed by the group aged 70-79 with 314,617 individuals (factor 1.45 and factor 1.28 increase in the male and female group, respectively, compared to 2019). Similar trends were found in the ageing and growing scenarios. CONCLUSIONS: The projected increase in the occurrence of OA will likely lead to a substantial socioeconomic burden for the Austrian healthcare system in the near and far future. The current findings plead for the development of sustainable concepts for the treatment and prevention of OA by European authorities. |
format | Online Article Text |
id | pubmed-8830022 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88300222022-02-11 Projected number of osteoarthritis patients in Austria for the next decades – quantifying the necessity of treatment and prevention strategies in Europe Hitzl, Wolfgang Stamm, Tanja Kloppenburg, Margreet Ritter, Markus Gaisberger, Martin van der Zee-Neuen, Antje BMC Musculoskelet Disord Research BACKGROUND: The present study aimed to predict the expected number of patients with osteoarthritis (OA) in Austria up to the year 2080. METHODS: Demographic data and population projections between 2019 and 2080 were obtained from European authorities. Information about recent age- and sex-stratified prevalence of patients with self-reported physician-diagnosed OA was obtained from the Austrian Health Interview Survey (n = 15,771). Projections were stratified by age and sex; sensitivity analyses were performed based on aging, main (most likely), and growth scenarios of the population. RESULTS: Based on the projection, the overall increase in the total number of patients with OA from 2019 to 2080 will be 38% for men and women. In 2019, the highest number of OA-patients nested in the groups of persons aged 70-79 (n = 238,749) and 60-69 (n = 237,729) years. In 2080, the 80+ age group is predicted to have the highest number of OA with 421,548 individuals (i.e. factor 3.45 and factor 2.48 increase in the male and female group, respectively, compared to 2019), followed by the group aged 70-79 with 314,617 individuals (factor 1.45 and factor 1.28 increase in the male and female group, respectively, compared to 2019). Similar trends were found in the ageing and growing scenarios. CONCLUSIONS: The projected increase in the occurrence of OA will likely lead to a substantial socioeconomic burden for the Austrian healthcare system in the near and far future. The current findings plead for the development of sustainable concepts for the treatment and prevention of OA by European authorities. BioMed Central 2022-02-09 /pmc/articles/PMC8830022/ /pubmed/35139829 http://dx.doi.org/10.1186/s12891-022-05091-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Hitzl, Wolfgang Stamm, Tanja Kloppenburg, Margreet Ritter, Markus Gaisberger, Martin van der Zee-Neuen, Antje Projected number of osteoarthritis patients in Austria for the next decades – quantifying the necessity of treatment and prevention strategies in Europe |
title | Projected number of osteoarthritis patients in Austria for the next decades – quantifying the necessity of treatment and prevention strategies in Europe |
title_full | Projected number of osteoarthritis patients in Austria for the next decades – quantifying the necessity of treatment and prevention strategies in Europe |
title_fullStr | Projected number of osteoarthritis patients in Austria for the next decades – quantifying the necessity of treatment and prevention strategies in Europe |
title_full_unstemmed | Projected number of osteoarthritis patients in Austria for the next decades – quantifying the necessity of treatment and prevention strategies in Europe |
title_short | Projected number of osteoarthritis patients in Austria for the next decades – quantifying the necessity of treatment and prevention strategies in Europe |
title_sort | projected number of osteoarthritis patients in austria for the next decades – quantifying the necessity of treatment and prevention strategies in europe |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830022/ https://www.ncbi.nlm.nih.gov/pubmed/35139829 http://dx.doi.org/10.1186/s12891-022-05091-5 |
work_keys_str_mv | AT hitzlwolfgang projectednumberofosteoarthritispatientsinaustriaforthenextdecadesquantifyingthenecessityoftreatmentandpreventionstrategiesineurope AT stammtanja projectednumberofosteoarthritispatientsinaustriaforthenextdecadesquantifyingthenecessityoftreatmentandpreventionstrategiesineurope AT kloppenburgmargreet projectednumberofosteoarthritispatientsinaustriaforthenextdecadesquantifyingthenecessityoftreatmentandpreventionstrategiesineurope AT rittermarkus projectednumberofosteoarthritispatientsinaustriaforthenextdecadesquantifyingthenecessityoftreatmentandpreventionstrategiesineurope AT gaisbergermartin projectednumberofosteoarthritispatientsinaustriaforthenextdecadesquantifyingthenecessityoftreatmentandpreventionstrategiesineurope AT vanderzeeneuenantje projectednumberofosteoarthritispatientsinaustriaforthenextdecadesquantifyingthenecessityoftreatmentandpreventionstrategiesineurope |